Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 19.900 | 20140606, Panzner P
| 3.1.1 - Source Sensitized (SPT) | 2003 | Italy | IgE | 749 | 42.700 | | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 3.230 | 20120528, Patelis A
| 3.2.1 - Source Sensitized (IgE) | 2002 | Not Defined | IgE | 184 | 32.100 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 103 | 18.200 | 20141003, Beitia JM
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Germany | IgE | 101 | 36.630 | 20140306, Darsow U
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 15.150 | 20110223, De Knop KJ
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 6.250 | 20120528, Patelis A
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 12.790 | 20101214, Gadisseur R
| 3.1.4 - Source Sensitized (SPT, IgE) | 2001 | Italy | IgE | 77 | 53.200 | | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 15.800 | 20131020, van Rhijn BD
| 3.2.1 - Source Sensitized (IgE) | 2005 | Finland | IgE | 57 | 35.000 | | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Austria | IgE | 54 | 16.700 | 20120310, Twaroch TE
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 20.000 | 20131014, Bokanovic D
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 12.000 | 20131014, Bokanovic D
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2011 | Spain | IgE | 43 | 20.900 | 20110713, Cabrera-Freitag P
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 16.210 | 20090826, Ebo DG
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 8.000 | 20140127, Konradsen JR
| 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 25.710 | 20130605, Simon D
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 14.000 | 20140127, Konradsen JR
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Italy | IgE | 26 | 23.100 | 20120310, Twaroch TE
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 13.640 | 20091121, Ebo DG
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 30.000 | 20091005, Ott H
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 20.000 | 20091121, Ebo DG
| 3.2.1 - Source Sensitized (IgE) | 2005 | Russian Federation | IgE | 12 | 8.300 | |
|